9 reports

  • LEADING TREATMENTS FOR BIPOLAR DISORDER, 2015
  • KEY COMPANIES IN THE BIPOLAR DISORDER MARKET IN THE 8MM, 2015

BIPOLAR DISORDERS; ##(##): ##- ##.

  • Antipsychotic
  • Bipolar Disorder
  • Epidemiology
  • Therapy
  • Eli Lilly & Co.
  • KEY COMPANIES IN THE BIPOLAR DISORDER MARKET IN THE 8MM, 2015
  • ELI LILLY'S BIPOLAR DISORDER PORTFOLIO ASSESSMENT, 2015

BIPOLAR DISORDERS; ##(##): ##- ##.

  • Bipolar Disorder
  • Market Size
  • Allergan plc
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • LEADING TREATMENTS FOR BIPOLAR DISORDER, 2015
  • 5.2 PRODUCT PROFILES - MAJOR BRANDS

Bipolar Disorders; ##(##): ##- ##.

  • Antipsychotic
  • Bipolar Disorder
  • Mental Health
  • Therapy
  • Eli Lilly & Co.
  • LEADING TREATMENTS FOR BIPOLAR DISORDER, 2015
  • 5.2 PRODUCT PROFILES - MAJOR BRANDS

Bipolar Disorders; ##(##): ##- ##.

  • Antipsychotic
  • Bipolar Disorder
  • Mental Health
  • Therapy
  • Eli Lilly & Co.
  • LEADING TREATMENTS FOR BIPOLAR DISORDER, 2015
  • 5.2 PRODUCT PROFILES - MAJOR BRANDS

Bipolar Disorders; ##(##): ##- ##.

  • Antipsychotic
  • Bipolar Disorder
  • Mental Health
  • Therapy
  • Eli Lilly & Co.
  • LEADING TREATMENTS FOR BIPOLAR DISORDER, 2015
  • 5.1 OVERVIEW

Bipolar Disorders; ##(##): ##- ##.

  • Antipsychotic
  • Bipolar Disorder
  • Mental Health
  • Therapy
  • Eli Lilly & Co.
  • Treatment: Bipolar Disorder
  • Marketed Drugs: Bipolar Disorder

Bipolar Disorders, ## (##), ##-## < DOI> ##. ##/ bdi. ##< / DOI>.

  • Bipolar Disorder
  • Mental Health
  • Therapy
  • Demand
  • Eli Lilly & Co.
  • Pipeline analysis
  • Impact of drivers

Bipolar I disorder Bipolar II disorder Cyclothymic disorder Bipolar disorder NOS (Not Otherwise Specified) In this state individuals experience one or more episodes of mania, or mixed episodes, and are often followed by

  • Bipolar Disorder
  • Therapy
  • Allergan plc
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • 3. GDCT ID is the unique ID of GlobalData's Pharma Intelligence Center clinical trial database

OPPOSITIONAL DEFIANT DISORDER (ODD) THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018* OPPOSITIONAL DEFIANT DISORDER (ODD) THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018* OPPOSITIONAL DEFIANT DISORDER (ODD) THERAPEUTICS CLINICAL TRIALS,

  • Bipolar Disorder
  • Therapy
  • World
  • Product Initiative
  • Eli Lilly & Co.